Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.

Click the orange button to the right to learn more about what you can start doing today.

Multiple Myeloma Chemotherapy- Evidence-Based, Non-Conventional

Share Button

The National Cancer Institute is working cooperatively with research centers across the U.S. to evaluate its clinical activity in hematologic malignancies… such as multiple myeloma

I was diagnosed with multiple myeloma in 2/94. I underwent VAD and Cytoxan induction therapy and an auto stem cell transplant in ’95. These toxic chemotherapies did little to manage my cancer yet led to short, long-term and late stage negative side effects. Where is it written that chemotherapy must be toxic to be cytotoxic multiple myeloma?

Image result for photo of multiple myeloma

Based on my negative experience with toxic “standard of care” chemotherapy regimens I am constantly on the lookout for therapies that hold promise for both overall survival as well as quality of life. While it it is too soon to make a decision about therapies from the studies linked below discussing Arsenic Trioxide, intravenous vitamin C and curcumin, it is clear that there is potential in keeping an eye on these therapies especially if you have a blood cancer that has relapsed.

I found a non-conventional therapy that put me into complete remission from my Multiple Myeloma. I encourage you to think outside the conventional therapy box if you have been diagnosed with a blood cancer.

Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.


For more information on both conventional and non-conventional cancer therapies, scroll down the page, post a question or comment and I will reply to you ASAP.

Thank you,

David Emerson

  • MM Survivor
  • MM Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:

Clinical Trials of Arsenic Trioxide in Hematologic and Solid Tumors: Overview of the National Cancer Institute Cooperative Research and Development Studies

Arsenic trioxide inhibits growth and promotes apoptosis in many different cancer cell lines. The National Cancer Institute is working cooperatively with research centers across the U.S. to evaluate its clinical activity in hematologic malignancies, such as acute promyelocytic leukemia, acute myeloid leukemia, acute lymphocytic leukemia, chronic myelogenous leukemia, non-Hodgkin’s lymphoma, Hodgkin’s disease, chronic lymphocytic leukemia, myelodysplastic syndrome, and multiple myeloma. It is also supporting research in solid tumors, such as advanced hormone-refractory prostate cancer and renal cell cancer and in cervical cancer and refractory transitional cell carcinoma of the bladder. The safety and pharmacokinetics of arsenic trioxide are also being evaluated in pediatric patients with refractory leukemia and lymphoma

Intravenously administered vitamin C as cancer therapy: three cases

“At concentrations above 1000 μmol/L, vitamin C is toxic to some cancer cells but not to normal cells in vitro. We found 3 well-documented cases of advanced cancers, confirmed by histopathologic review, where patients had unexpectedly long survival times after receiving high-dose intravenous vitamin C therapy.

Chinese Folk Treatment Reveals Power of Arsenic To Treat Cancer, New Studies Under Way

While arsenic has had its greatest success in APL, it is also being tested in a variety of other cancers. There are 17 ongoing clinical trials in the United States testing arsenic trioxide to treat various forms of leukemia and cancers of the central nervous system and brain, according to the National Institutes of Health Web site http://www.clinicaltrials.gov

If you have something that will take away the potential toxicity and the potential real harm of high doses of anthracycline [chemotherapy] why not do it?”

The Most BioAvailable Curcumin Formulas

“Based on a review of these studies, it is evident that better bioavailability of formulated curcumin (CU) products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism”

A search of the Pubmed database for the word curcumin yields 601 studies spaning health topics from multiple myeloma and colorectal cancer, to chemotherapies that synergizes with CU, to Alzheimer’s Disease, arthritis and more. Based on years of reading studies and personal accounts, I think it is safe to say that CU supplementation is safe and relatively inexpensive.

I have read about myeloma patients taking daily doses of CU from 400 milligrams to 8 grams (1000 milligrams = 1 gram). By almost any measure, CU is a safe, inexpensive wonder drug.

The only challenge is that CU is famously difficult to absorb in the body. In other words, a person has to mix curcumin with some sort of fat (coconut oil, chocolate, etc.) or take a brand of curcumin capsule that is already formulated to be more “bioavailable” in order to derive the full benefit of CU.

The study linked and exerpted below reviews different formulations of CU. The study itself lists the three most bioavailable formulation/brand of CU and I’ve added an excerpt from a further review from Consumerlab.com that lists four additional bioavailable brands of CU.

Recommended Reading:


CU is a bright yellow chemical produced by some plants. It is the principal curcuminoid of turmeric (Curcuma longa), a member of the ginger family, Zingiberaceae. It is sold as an herbal supplement, cosmetics ingredient, food flavoring, and food coloring.[1]

Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers.

“Curcumin is a widely studied natural compound which has shown tremendous in vitro therapeutic potential. Despite that, the clinical efficacy of the native CU is weak due to its low bioavailability and high metabolism in the gastrointestinal tract. During the last decade, researchers have come up with different formulations with a focus on improving the bioavailability of curcumin. As a result, a significant number of bioavailable curcumin-based formulations were introduced with the varying range of enhanced bioavailability.

The purpose of this review is to collate the published clinical studies of CU products with improved bioavailability over conventional (unformulated) CU. Based on the literature search, 11 curcumin formulations with available human bioavailability and pharmacokinetics data were included in this review. Further, the data on clinical study design, analytical method, pharmacokinetic parameters and other relevant details of each formulation were extracted.

Based on a review of these studies, it is evident that better bioavailability of formulated curcumin products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism. The review hopes to provide a quick reference guide for anyone looking information on these bioavailable curcumin formulations.

Based on the published reports,

exhibited over 100-fold higher bioavailability relative to reference unformulated CU. Suggested mechanisms accounting for improved bioavailability of the formulations and details on the bioanalysis methods are also discussed.”

According to Consumerlab.com:

“Novasol has the highest bioavailability (185 x compared to unforumulated CU), followed by Curcuwin (136 x), Longvida (100 x), Meriva (48 x), BCM-95 (27 x), Curcumin C3 Complex + Bioperene (20 x), and then Theracumin (16 x).”

Leave a Comment:

Multiple Myeloma Diagnosis - A How-To Guide says last year

[…] Learn about and include evidence-based, non-toxic, non-conventional therapies- […]

Smoldering Multiple Myeloma- Monoclonal Gammopathy of Renal Significance? - PeopleBeatingCancer says a couple of years ago

[…] Multiple Myeloma Chemotherapy- Evidence-Based, Non-Conventional […]

Top Multiple Myeloma Hospitals, Multiple Myeloma Specialists - PeopleBeatingCancer says 3 years ago

[…] Multiple Myeloma Chemotherapy- Evidence-Based, Non-Conventional […]

C-B-D kills multiple myeloma and enhances Velcade - PeopleBeatingCancer says 4 years ago

[…] Multiple Myeloma Chemotherapy- Evidence-Based, Non-Conventional […]

Add Your Reply